Pralidoxime Chloride

CHEMBL748 Phase 4 已批准 Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

172.6 g/mol

LogP

—

Phase

4

Pralidoxime chloride is the chloride salt form of pralidoxime, an acetylcholinesterase reactivator used in the treatment of organophosphate poisoning to restore cholinesterase activity by nucleophilic displacement of the organophosphate from the inhibited enzyme. See pralidoxime for complete pharmacological details.

分子量

172.6100 g/mol

TPSA

36.50 Å²

Pharmacokinetics (PK)

Pharmacodynamics (PD)

二维结构

SVG PNG

Cite this structure

Embed this structure

SMILES

C[n+]1ccccc1/C=N/O.[Cl-]

InChI

InChI=1S/C7H8N2O.ClH/c1-9-5-3-2-4-7(9)6-8-10;/h2-6H,1H3;1H

Molecular Formula

C7H9ClN2O

HBD / HBA

1 / 3

可旋转键数

1

重原子数

11

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

常见问题

Pralidoxime chloride is the chloride salt form of pralidoxime, an acetylcholinesterase reactivator used in the treatment of organophosphate poisoning to restore cholinesterase activity by nucleophilic displacement of the organophosphate from the inhibited enzyme. See pralidoxime for complete pharmacological details.

Yes, Pralidoxime Chloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL748. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 135445761. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

正在寻找患者友好型信息？

Pralidoxime Chloride 在 PillFYI 上

结构

快速数据

分子式: C7H9ClN2O
同义词: 3

外部链接

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

医疗免责声明

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.